Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
macitentan (opsumit) (2 trials)
Heart Diseases (Phase 3)
Heart Failure (Phase 2)
Vascular Diseases (Phase 2)
Trials (2 total)
Trial APIs (1 total)